Global Mesalamine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 262705
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Mesalamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Mesalamine market size is estimated to be worth US$ 161 million in 2021 and is forecast to a readjusted size of USD 198.9 million by 2028 with a CAGR of 3.1% during review period. Mesalazine Tablets accounting for % of the Mesalamine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Purity ≥ 97% segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Mesalamine include Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories, and Hangzhou Brother, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Mesalamine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Purity ≥ 97%

Purity ≥ 98%

Purity ≥ 99%

Market segment by Application can be divided into

Mesalazine Tablets

Mesalazine Capsules

Others

The key market players for global Mesalamine market are listed below:

Syntese A/S

Divis Laboratories

Cambrex Corporation

Ipca Laboratories

Hangzhou Brother

PharmaZell

Lianyungang Fengheng Biopharm

Lasa Loboratory

Erregierre SpA

Corden Pharma Bergamo

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Mesalamine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Mesalamine, with price, sales, revenue and global market share of Mesalamine from 2019 to 2022.

Chapter 3, the Mesalamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Mesalamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Mesalamine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Mesalamine.

Chapter 13, 14, and 15, to describe Mesalamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Mesalamine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Mesalamine Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Purity ≥ 97%

1.2.3 Purity ≥ 98%

1.2.4 Purity ≥ 99%

1.3 Market Analysis by Application

1.3.1 Overview: Global Mesalamine Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Mesalazine Tablets

1.3.3 Mesalazine Capsules

1.3.4 Others

1.4 Global Mesalamine Market Size & Forecast

1.4.1 Global Mesalamine Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Mesalamine Sales in Volume (2017-2028)

1.4.3 Global Mesalamine Price (2017-2028)

1.5 Global Mesalamine Production Capacity Analysis

1.5.1 Global Mesalamine Total Production Capacity (2017-2028)

1.5.2 Global Mesalamine Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Mesalamine Market Drivers

1.6.2 Mesalamine Market Restraints

1.6.3 Mesalamine Trends Analysis

2 Manufacturers Profiles

2.1 Syntese A/S

2.1.1 Syntese A/S Details

2.1.2 Syntese A/S Major Business

2.1.3 Syntese A/S Mesalamine Product and Services

2.1.4 Syntese A/S Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Divis Laboratories

2.2.1 Divis Laboratories Details

2.2.2 Divis Laboratories Major Business

2.2.3 Divis Laboratories Mesalamine Product and Services

2.2.4 Divis Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Cambrex Corporation

2.3.1 Cambrex Corporation Details

2.3.2 Cambrex Corporation Major Business

2.3.3 Cambrex Corporation Mesalamine Product and Services

2.3.4 Cambrex Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Ipca Laboratories

2.4.1 Ipca Laboratories Details

2.4.2 Ipca Laboratories Major Business

2.4.3 Ipca Laboratories Mesalamine Product and Services

2.4.4 Ipca Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Hangzhou Brother

2.5.1 Hangzhou Brother Details

2.5.2 Hangzhou Brother Major Business

2.5.3 Hangzhou Brother Mesalamine Product and Services

2.5.4 Hangzhou Brother Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 PharmaZell

2.6.1 PharmaZell Details

2.6.2 PharmaZell Major Business

2.6.3 PharmaZell Mesalamine Product and Services

2.6.4 PharmaZell Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Lianyungang Fengheng Biopharm

2.7.1 Lianyungang Fengheng Biopharm Details

2.7.2 Lianyungang Fengheng Biopharm Major Business

2.7.3 Lianyungang Fengheng Biopharm Mesalamine Product and Services

2.7.4 Lianyungang Fengheng Biopharm Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Lasa Loboratory

2.8.1 Lasa Loboratory Details

2.8.2 Lasa Loboratory Major Business

2.8.3 Lasa Loboratory Mesalamine Product and Services

2.8.4 Lasa Loboratory Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Erregierre SpA

2.9.1 Erregierre SpA Details

2.9.2 Erregierre SpA Major Business

2.9.3 Erregierre SpA Mesalamine Product and Services

2.9.4 Erregierre SpA Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Corden Pharma Bergamo

2.10.1 Corden Pharma Bergamo Details

2.10.2 Corden Pharma Bergamo Major Business

2.10.3 Corden Pharma Bergamo Mesalamine Product and Services

2.10.4 Corden Pharma Bergamo Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 CTX Lifescience

2.11.1 CTX Lifescience Details

2.11.2 CTX Lifescience Major Business

2.11.3 CTX Lifescience Mesalamine Product and Services

2.11.4 CTX Lifescience Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12 Ishita Active Pharma Ingredients

2.12.1 Ishita Active Pharma Ingredients Details

2.12.2 Ishita Active Pharma Ingredients Major Business

2.12.3 Ishita Active Pharma Ingredients Mesalamine Product and Services

2.12.4 Ishita Active Pharma Ingredients Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13 YC Biotech (Jiangsu)

2.13.1 YC Biotech (Jiangsu) Details

2.13.2 YC Biotech (Jiangsu) Major Business

2.13.3 YC Biotech (Jiangsu) Mesalamine Product and Services

2.13.4 YC Biotech (Jiangsu) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14 Xinxiang Tianfeng Fine Chemical

2.14.1 Xinxiang Tianfeng Fine Chemical Details

2.14.2 Xinxiang Tianfeng Fine Chemical Major Business

2.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services

2.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Mesalamine Breakdown Data by Manufacturer

3.1 Global Mesalamine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Mesalamine Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Mesalamine

3.4 Market Concentration Rate

3.4.1 Top 3 Mesalamine Manufacturer Market Share in 2021

3.4.2 Top 6 Mesalamine Manufacturer Market Share in 2021

3.5 Global Mesalamine Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Mesalamine Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Mesalamine Market Size by Region

4.1.1 Global Mesalamine Sales in Volume by Region (2017-2028)

4.1.2 Global Mesalamine Revenue by Region (2017-2028)

4.2 North America Mesalamine Revenue (2017-2028)

4.3 Europe Mesalamine Revenue (2017-2028)

4.4 Asia-Pacific Mesalamine Revenue (2017-2028)

4.5 South America Mesalamine Revenue (2017-2028)

4.6 Middle East and Africa Mesalamine Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Mesalamine Sales in Volume by Type (2017-2028)

5.2 Global Mesalamine Revenue by Type (2017-2028)

5.3 Global Mesalamine Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Mesalamine Sales in Volume by Application (2017-2028)

6.2 Global Mesalamine Revenue by Application (2017-2028)

6.3 Global Mesalamine Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Mesalamine Sales by Type (2017-2028)

7.2 North America Mesalamine Sales by Application (2017-2028)

7.3 North America Mesalamine Market Size by Country

7.3.1 North America Mesalamine Sales in Volume by Country (2017-2028)

7.3.2 North America Mesalamine Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Mesalamine Sales by Type (2017-2028)

8.2 Europe Mesalamine Sales by Application (2017-2028)

8.3 Europe Mesalamine Market Size by Country

8.3.1 Europe Mesalamine Sales in Volume by Country (2017-2028)

8.3.2 Europe Mesalamine Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Mesalamine Sales by Type (2017-2028)

9.2 Asia-Pacific Mesalamine Sales by Application (2017-2028)

9.3 Asia-Pacific Mesalamine Market Size by Region

9.3.1 Asia-Pacific Mesalamine Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Mesalamine Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Mesalamine Sales by Type (2017-2028)

10.2 South America Mesalamine Sales by Application (2017-2028)

10.3 South America Mesalamine Market Size by Country

10.3.1 South America Mesalamine Sales in Volume by Country (2017-2028)

10.3.2 South America Mesalamine Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Mesalamine Sales by Type (2017-2028)

11.2 Middle East & Africa Mesalamine Sales by Application (2017-2028)

11.3 Middle East & Africa Mesalamine Market Size by Country

11.3.1 Middle East & Africa Mesalamine Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Mesalamine Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Mesalamine and Key Manufacturers

12.2 Manufacturing Costs Percentage of Mesalamine

12.3 Mesalamine Production Process

12.4 Mesalamine Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Mesalamine Typical Distributors

13.3 Mesalamine Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Mesalamine Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Mesalamine Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Syntese A/S Basic Information, Manufacturing Base and Competitors

Table 4. Syntese A/S Major Business

Table 5. Syntese A/S Mesalamine Product and Services

Table 6. Syntese A/S Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Divis Laboratories Basic Information, Manufacturing Base and Competitors

Table 8. Divis Laboratories Major Business

Table 9. Divis Laboratories Mesalamine Product and Services

Table 10. Divis Laboratories Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Cambrex Corporation Basic Information, Manufacturing Base and Competitors

Table 12. Cambrex Corporation Major Business

Table 13. Cambrex Corporation Mesalamine Product and Services

Table 14. Cambrex Corporation Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Ipca Laboratories Basic Information, Manufacturing Base and Competitors

Table 16. Ipca Laboratories Major Business

Table 17. Ipca Laboratories Mesalamine Product and Services

Table 18. Ipca Laboratories Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Hangzhou Brother Basic Information, Manufacturing Base and Competitors

Table 20. Hangzhou Brother Major Business

Table 21. Hangzhou Brother Mesalamine Product and Services

Table 22. Hangzhou Brother Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. PharmaZell Basic Information, Manufacturing Base and Competitors

Table 24. PharmaZell Major Business

Table 25. PharmaZell Mesalamine Product and Services

Table 26. PharmaZell Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Lianyungang Fengheng Biopharm Basic Information, Manufacturing Base and Competitors

Table 28. Lianyungang Fengheng Biopharm Major Business

Table 29. Lianyungang Fengheng Biopharm Mesalamine Product and Services

Table 30. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Lasa Loboratory Basic Information, Manufacturing Base and Competitors

Table 32. Lasa Loboratory Major Business

Table 33. Lasa Loboratory Mesalamine Product and Services

Table 34. Lasa Loboratory Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Erregierre SpA Basic Information, Manufacturing Base and Competitors

Table 36. Erregierre SpA Major Business

Table 37. Erregierre SpA Mesalamine Product and Services

Table 38. Erregierre SpA Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Corden Pharma Bergamo Basic Information, Manufacturing Base and Competitors

Table 40. Corden Pharma Bergamo Major Business

Table 41. Corden Pharma Bergamo Mesalamine Product and Services

Table 42. Corden Pharma Bergamo Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. CTX Lifescience Basic Information, Manufacturing Base and Competitors

Table 44. CTX Lifescience Major Business

Table 45. CTX Lifescience Mesalamine Product and Services

Table 46. CTX Lifescience Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Ishita Active Pharma Ingredients Basic Information, Manufacturing Base and Competitors

Table 48. Ishita Active Pharma Ingredients Major Business

Table 49. Ishita Active Pharma Ingredients Mesalamine Product and Services

Table 50. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 51. YC Biotech (Jiangsu) Basic Information, Manufacturing Base and Competitors

Table 52. YC Biotech (Jiangsu) Major Business

Table 53. YC Biotech (Jiangsu) Mesalamine Product and Services

Table 54. YC Biotech (Jiangsu) Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 55. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base and Competitors

Table 56. Xinxiang Tianfeng Fine Chemical Major Business

Table 57. Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services

Table 58. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 59. Global Mesalamine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)

Table 60. Global Mesalamine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 61. Market Position of Manufacturers in Mesalamine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 62. Global Mesalamine Production Capacity by Company, (MT): 2020 VS 2021

Table 63. Head Office and Mesalamine Production Site of Key Manufacturer

Table 64. Mesalamine New Entrant and Capacity Expansion Plans

Table 65. Mesalamine Mergers & Acquisitions in the Past Five Years

Table 66. Global Mesalamine Sales by Region (2017-2022) & (MT)

Table 67. Global Mesalamine Sales by Region (2023-2028) & (MT)

Table 68. Global Mesalamine Revenue by Region (2017-2022) & (USD Million)

Table 69. Global Mesalamine Revenue by Region (2023-2028) & (USD Million)

Table 70. Global Mesalamine Sales by Type (2017-2022) & (MT)

Table 71. Global Mesalamine Sales by Type (2023-2028) & (MT)

Table 72. Global Mesalamine Revenue by Type (2017-2022) & (USD Million)

Table 73. Global Mesalamine Revenue by Type (2023-2028) & (USD Million)

Table 74. Global Mesalamine Price by Type (2017-2022) & (USD/Kg)

Table 75. Global Mesalamine Price by Type (2023-2028) & (USD/Kg)

Table 76. Global Mesalamine Sales by Application (2017-2022) & (MT)

Table 77. Global Mesalamine Sales by Application (2023-2028) & (MT)

Table 78. Global Mesalamine Revenue by Application (2017-2022) & (USD Million)

Table 79. Global Mesalamine Revenue by Application (2023-2028) & (USD Million)

Table 80. Global Mesalamine Price by Application (2017-2022) & (USD/Kg)

Table 81. Global Mesalamine Price by Application (2023-2028) & (USD/Kg)

Table 82. North America Mesalamine Sales by Country (2017-2022) & (MT)

Table 83. North America Mesalamine Sales by Country (2023-2028) & (MT)

Table 84. North America Mesalamine Revenue by Country (2017-2022) & (USD Million)

Table 85. North America Mesalamine Revenue by Country (2023-2028) & (USD Million)

Table 86. North America Mesalamine Sales by Type (2017-2022) & (MT)

Table 87. North America Mesalamine Sales by Type (2023-2028) & (MT)

Table 88. North America Mesalamine Sales by Application (2017-2022) & (MT)

Table 89. North America Mesalamine Sales by Application (2023-2028) & (MT)

Table 90. Europe Mesalamine Sales by Country (2017-2022) & (MT)

Table 91. Europe Mesalamine Sales by Country (2023-2028) & (MT)

Table 92. Europe Mesalamine Revenue by Country (2017-2022) & (USD Million)

Table 93. Europe Mesalamine Revenue by Country (2023-2028) & (USD Million)

Table 94. Europe Mesalamine Sales by Type (2017-2022) & (MT)

Table 95. Europe Mesalamine Sales by Type (2023-2028) & (MT)

Table 96. Europe Mesalamine Sales by Application (2017-2022) & (MT)

Table 97. Europe Mesalamine Sales by Application (2023-2028) & (MT)

Table 98. Asia-Pacific Mesalamine Sales by Region (2017-2022) & (MT)

Table 99. Asia-Pacific Mesalamine Sales by Region (2023-2028) & (MT)

Table 100. Asia-Pacific Mesalamine Revenue by Region (2017-2022) & (USD Million)

Table 101. Asia-Pacific Mesalamine Revenue by Region (2023-2028) & (USD Million)

Table 102. Asia-Pacific Mesalamine Sales by Type (2017-2022) & (MT)

Table 103. Asia-Pacific Mesalamine Sales by Type (2023-2028) & (MT)

Table 104. Asia-Pacific Mesalamine Sales by Application (2017-2022) & (MT)

Table 105. Asia-Pacific Mesalamine Sales by Application (2023-2028) & (MT)

Table 106. South America Mesalamine Sales by Country (2017-2022) & (MT)

Table 107. South America Mesalamine Sales by Country (2023-2028) & (MT)

Table 108. South America Mesalamine Revenue by Country (2017-2022) & (USD Million)

Table 109. South America Mesalamine Revenue by Country (2023-2028) & (USD Million)

Table 110. South America Mesalamine Sales by Type (2017-2022) & (MT)

Table 111. South America Mesalamine Sales by Type (2023-2028) & (MT)

Table 112. South America Mesalamine Sales by Application (2017-2022) & (MT)

Table 113. South America Mesalamine Sales by Application (2023-2028) & (MT)

Table 114. Middle East & Africa Mesalamine Sales by Region (2017-2022) & (MT)

Table 115. Middle East & Africa Mesalamine Sales by Region (2023-2028) & (MT)

Table 116. Middle East & Africa Mesalamine Revenue by Region (2017-2022) & (USD Million)

Table 117. Middle East & Africa Mesalamine Revenue by Region (2023-2028) & (USD Million)

Table 118. Middle East & Africa Mesalamine Sales by Type (2017-2022) & (MT)

Table 119. Middle East & Africa Mesalamine Sales by Type (2023-2028) & (MT)

Table 120. Middle East & Africa Mesalamine Sales by Application (2017-2022) & (MT)

Table 121. Middle East & Africa Mesalamine Sales by Application (2023-2028) & (MT)

Table 122. Mesalamine Raw Material

Table 123. Key Manufacturers of Mesalamine Raw Materials

Table 124. Direct Channel Pros & Cons

Table 125. Indirect Channel Pros & Cons

Table 126. Mesalamine Typical Distributors

Table 127. Mesalamine Typical Customers

List of Figures

Figure 1. Mesalamine Picture

Figure 2. Global Mesalamine Revenue Market Share by Type in 2021

Figure 3. Purity ≥ 97%

Figure 4. Purity ≥ 98%

Figure 5. Purity ≥ 99%

Figure 6. Global Mesalamine Revenue Market Share by Application in 2021

Figure 7. Mesalazine Tablets

Figure 8. Mesalazine Capsules

Figure 9. Others

Figure 10. Global Mesalamine Revenue, (USD Million) & (MT): 2017 & 2021 & 2028

Figure 11. Global Mesalamine Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Mesalamine Sales (2017-2028) & (MT)

Figure 13. Global Mesalamine Price (2017-2028) & (USD/Kg)

Figure 14. Global Mesalamine Production Capacity (2017-2028) & (MT)

Figure 15. Global Mesalamine Production Capacity by Geographic Region: 2022 VS 2028

Figure 16. Mesalamine Market Drivers

Figure 17. Mesalamine Market Restraints

Figure 18. Mesalamine Market Trends

Figure 19. Global Mesalamine Sales Market Share by Manufacturer in 2021

Figure 20. Global Mesalamine Revenue Market Share by Manufacturer in 2021

Figure 21. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 22. Top 3 Mesalamine Manufacturer (Revenue) Market Share in 2021

Figure 23. Top 6 Mesalamine Manufacturer (Revenue) Market Share in 2021

Figure 24. Global Mesalamine Sales Market Share by Region (2017-2028)

Figure 25. Global Mesalamine Revenue Market Share by Region (2017-2028)

Figure 26. North America Mesalamine Revenue (2017-2028) & (USD Million)

Figure 27. Europe Mesalamine Revenue (2017-2028) & (USD Million)

Figure 28. Asia-Pacific Mesalamine Revenue (2017-2028) & (USD Million)

Figure 29. South America Mesalamine Revenue (2017-2028) & (USD Million)

Figure 30. Middle East & Africa Mesalamine Revenue (2017-2028) & (USD Million)

Figure 31. Global Mesalamine Sales Market Share by Type (2017-2028)

Figure 32. Global Mesalamine Revenue Market Share by Type (2017-2028)

Figure 33. Global Mesalamine Price by Type (2017-2028) & (USD/Kg)

Figure 34. Global Mesalamine Sales Market Share by Application (2017-2028)

Figure 35. Global Mesalamine Revenue Market Share by Application (2017-2028)

Figure 36. Global Mesalamine Price by Application (2017-2028) & (USD/Kg)

Figure 37. North America Mesalamine Sales Market Share by Type (2017-2028)

Figure 38. North America Mesalamine Sales Market Share by Application (2017-2028)

Figure 39. North America Mesalamine Sales Market Share by Country (2017-2028)

Figure 40. North America Mesalamine Revenue Market Share by Country (2017-2028)

Figure 41. United States Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Mesalamine Sales Market Share by Type (2017-2028)

Figure 45. Europe Mesalamine Sales Market Share by Application (2017-2028)

Figure 46. Europe Mesalamine Sales Market Share by Country (2017-2028)

Figure 47. Europe Mesalamine Revenue Market Share by Country (2017-2028)

Figure 48. Germany Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Mesalamine Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Mesalamine Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Mesalamine Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Mesalamine Revenue Market Share by Region (2017-2028)

Figure 57. China Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Korea Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Mesalamine Sales Market Share by Type (2017-2028)

Figure 64. South America Mesalamine Sales Market Share by Application (2017-2028)

Figure 65. South America Mesalamine Sales Market Share by Country (2017-2028)

Figure 66. South America Mesalamine Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East & Africa Mesalamine Sales Market Share by Type (2017-2028)

Figure 70. Middle East & Africa Mesalamine Sales Market Share by Application (2017-2028)

Figure 71. Middle East & Africa Mesalamine Sales Market Share by Region (2017-2028)

Figure 72. Middle East & Africa Mesalamine Revenue Market Share by Region (2017-2028)

Figure 73. Turkey Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Egypt Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Africa Mesalamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Manufacturing Cost Structure Analysis of Mesalamine in 2021

Figure 78. Manufacturing Process Analysis of Mesalamine

Figure 79. Mesalamine Industrial Chain

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source